Literature DB >> 2119481

Production of murine V-human Cr1 chimeric anti-TAG72 antibody using V region cDNA amplified by PCR.

J H Xiang1, J Roder, N Hozumi.   

Abstract

A mouse/human chimeric B72.3-1-3 antibody was produced by construction of a novel expression vector mpSV2neo-EP1-V-Cr1. This vector contains the neo gene as a selection marker, the murine immunoglobulin heavy chain promoter and enhancer, the murine V region cDNA containing mRNA splicing joint sequences, amplified and cloned by the PCR technique directly from the B72.3 hybridoma RNA, and the human genomic Cr1 region. The expression vector containing the murine/human chimeric immunoglobulin heavy chain gene was transfected into heavy chain loss mutant cell line, B72.3Ml. Chimeric B72.3-1-3 antibody was produced at 2 micrograms/ml and retained full binding reactivity to TAG72 compared to the murine B72.3 parental antibody. Using this method, chimeric immunoglobulin molecules can be produced rapidly in comparison with the cDNA and genomic cloning techniques.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2119481     DOI: 10.1016/0161-5890(90)90091-d

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  7 in total

1.  Genetic engineering of high affinity anti-human colorectal tumour mouse/human chimeric antibody.

Authors:  J Xiang; Z Chen
Journal:  Immunology       Date:  1992-02       Impact factor: 7.397

2.  Development of oligoclonal nanobodies for targeting the tumor-associated glycoprotein 72 antigen.

Authors:  Zahra Sharifzadeh; Fatemeh Rahbarizadeh; Mohammad Ali Shokrgozar; Davoud Ahmadvand; Fereidoun Mahboudi; Fatemeh Rahimi Jamnani; Seyed Hamid Aghaee Bakhtiari
Journal:  Mol Biotechnol       Date:  2013-06       Impact factor: 2.695

3.  Production of a bifunctional hybrid molecule B72.3/metallothionein-1 by protein engineering.

Authors:  J Xiang; J Koropatnick; Y Qi; X Luo; T Moyana; K Li; Y Chen
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

4.  High-affinity chimeric anti-(colorectal carcinoma) antibody correlated to enhanced tumor targeting in biodistribution and imaging.

Authors:  Y Qi; G Matte; A Wilkinson; X Jim
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

Review 5.  Problems of delivery of monoclonal antibodies. Pharmaceutical and pharmacokinetic solutions.

Authors:  R M Reilly; J Sandhu; T M Alvarez-Diez; S Gallinger; J Kirsh; H Stern
Journal:  Clin Pharmacokinet       Date:  1995-02       Impact factor: 6.447

6.  A human/mouse chimeric monoclonal antibody against intercellular adhesion molecule-1 for tumor radioimmunoimaging.

Authors:  M Yamamura; Y Hinoda; S Sasaki; M Tsujisaki; N Oriuchi; K Endo; K Imai
Journal:  Jpn J Cancer Res       Date:  1996-04

7.  Establishment and characterization of mouse-human chimeric monoclonal antibody to erbB-2 product.

Authors:  T Ishida; M Tsujisaki; Y Hinoda; K Imai; A Yachi
Journal:  Jpn J Cancer Res       Date:  1994-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.